Not logged in Primary Uterine Nongestational Placental Site Trophoblastic Tumor as a Distinct Entity Trecourt, Alexis; Maher, Geoffrey J.; Fisher, Rosemary A.; Mcdonald, Katie; Seckl, Michael J.; Winter, Matthew C.; Susnjar, Snezana; Kesic, Vesna; Descargues, Pierre; Devouassoux-Shisheboran, Mojgan; Allias, Fabienne; Kaur, Baljeet Share Save
Share Save
Share Save
Monitoring complete hydatidiform molar pregnancies after normalisation of human chorionic gonadotrophin: national retrospective population study Swift, Brenna E.; Coopmans, Leonoor; Singh, Kam; Coyle, Christopher; Wilkes, Edmund H.; Jabbar, Imran; Maher, Geoffrey; Aguiar, Xianne; Salman, Lina; Palmer, Julia E.; Sarwar, Naveed; Caldwell, Reece; Ghorani, Eshan; Kaur, Baljeet; van Trommel, Nienke E.; Lok, Christianne A. R.; Winter, Matthew; Seckl, Michael J. Share Save
Share Save
Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles Rezaei, Maryam; Liang, Manqi; Yalcin, Zeynep; Martin, Jacinta H.; Kazemi, Parinaz; Bareke, Eric; Ge, Zhao-Jia; Fardaei, Majid; Benadiva, Claudio; Hemida, Reda; Hassan, Adnan; Maher, Geoffrey J.; Abdalla, Ebtesam; Buckett, William; Bolze, Pierre-Adrien; Sandhu, Iqbaljit; Duman, Onur; Agrawal, Suraksha; Qian, Jianhua; Broojeni, Jalal Vallian; Bhati, Lavi; Miron, Pierre; Allias, Fabienne; Selim, Amal; Fisher, Rosemary A.; Seckl, Michael J.; Sauthier, Philippe; Touitou, Isabelle; Tan, Seang Lin; Majewski, Jacek; Taketo, Teruko; Slim, Rima Share Save
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN Blay, Jean-Yves; Casali, Paolo; Ray-Coquard, Isabelle; Seckl, Michael J.; Gietema, Jourik; de Herder, Wouter W.; Caplin, Martyn; Klumpen, Heinz-Josef; Glehen, Olivier; Wyrwicz, Lucjan; Peeters, Robin; Licitra, Lisa; Girard, Nicolas; Piperno-Neumann, Sophie; Kapiteijn, Ellen; Idbaih, Ahmed; Franceschi, Enrico; Trama, Annalisa; Frezza, Anna-Maria; Hohenberger, Peter; Hindi, Nadia; Martin-Broto, Javier; Schell, Johanna; Rogasik, Muriel; Lejeune, Stephane; Oliver, Kathy; de Lorenzo, Francesco; Weinmanv, Ariane Share Save
Share Save
Share Save
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells Chrisochoidou, Yakinthi; Roy, Rajat; Farahmand, Pooyeh; Gonzalez, Guadalupe; Doig, Jennifer; Krasny, Lukas; Rimmer, Ella F.; Willis, Anne E.; MacFarlane, Marion; Huang, Paul H.; Carragher, Neil O.; Munro, Alison F.; Murphy, Daniel J.; Veselkov, Kirill; Seckl, Michael J.; Moffatt, Miriam F.; Cookson, William O. C.; Pardo, Olivier E. Share Save
REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design Ghorani, E.; Quartagno, M.; Blackhall, F.; Gilbert, D. C.; O'Brien, M. E. R.; Ottensmeier, C. H. H.; Pizzo, E.; Spicer, J.; Williams, A.; Badman, P.; Milner-Watts, C.; Parmar, M. K.; Seckl, M. J. Share Save
Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells Pardo, OE; Lesay, A; Arcaro, A; Lopes, R; Ng, BL; Warne, PH; McNeish, IA; Tetley, TD; Lemoine, NR; Mehmet, H; Seckl, MJ; Downward, J Share Save
Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells (vol 23, pg 7600, 2003) Pardo, OE; Lesay, A; Arcaro, A; Lopes, R; Ng, BL; Warne, PH; McNeish, IA; Tetley, TD; Lemoine, NR; Mehmet, H; Seckl, MJ; Downward, J Share Save
Share Save
Share Save
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer (vol 13, 3246, 2022) Coombes, R. C.; Badman, P. D.; Lozano-Kuehne, J. P.; Liu, X.; Macpherson, I. R.; Zubairi, I.; Baird, R. D.; Rosenfeld, N.; Garcia-Corbacho, J.; Cresti, N.; Plummer, R.; Armstrong, A.; Allerton, R.; Landers, D.; Nicholas, H.; McLellan, L.; Lim, A.; Mouliere, F.; Pardo, O. E.; Ferguson, V.; Seckl, M. J. Share Save
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer Coombes, R. C.; Badman, P. D.; Lozano-Kuehne, J. P.; Liu, X.; Macpherson, I. R.; Zubairi, I; Baird, R. D.; Rosenfeld, N.; Garcia-Corbacho, J.; Cresti, N.; Plummer, R.; Armstrong, A.; Allerton, R.; Landers, D.; Nicholas, H.; McLellan, L.; Lim, A.; Mouliere, F.; Pardo, O. E.; Seckl, M. J. Share Save
ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma (vol 4, pg 2540, 2022) Georgiou, Marina; Ntavelou, Panagiota; Stokes, William; Roy, Rajat; Maher, Geoffrey J.; Stoilova, Tsvetana; Choo, Josephine A. M. Y.; Rakhit, Callum P.; Martins, Miguel; Ajuh, Paul; Horowitz, Neil; Berkowitz, Ross S.; Elias, Kevin; Seckl, Michael J.; Pardo, Olivier E. Share Save
Share Save
Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia Clark, J.; Suyanto, S.; Hennah, L.; Winter, M.; Joneborg, U.; Wallin, E.; Harry, A.; Naban, N.; Kaur, B.; Aguiar, X.; Tin, T.; Sarwar, N.; Gonzalez, M.; Seckl, M. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
